Abstract

We studied the antimicrobial properties of 32 new non-protein compounds synthetized in the Scientific and Production Center “Armbiotechnology” by the method of asymmetric synthesis; new analogs of L-histidine and L-isoleucine were found. Via chemical mutagenesis, we obtained new mutants of the wild strain of Brevibacterium flavum 14067 resistant to (S)-β-[4-phenyl-3-(3’-hydroxypropyl)-5-thioxo-1,2,4-thiazole-1-yl]-α-alanine (an analog of histidine) and to (2S,3R)-oxyleucine (an analog of isoleucine). It was found that the synthesis rate of histidine and isoleucine in some mutants is higher than that of most active strain-producers resistant to one of these amino acids analogs described in literature. Our data prove the efficacy of the use of new analogs as selective agents for the screening of highly active strains producing histidine and isoleucine.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.